Dew,
I am disappointed in you. You forgot to directly repeat your mantra that both LEO and GTCB have been publically lying when they said the change had nothing to do with safety or efficacy. I guess that fact they it took forever for LEO to even come close to getting pricing set in a broad array of European countries doesn't speak to LEO's lack of committment, lack of competency or perhaps both. The DIC trial recruitment was slow and you have no idea how many patients were treated, yet you somehow know that LEO determined it was a failure and that both GTCB and LEO are still conspiring to lie about this. This is what was re-iterated today.
<As previously disclosed, LEO had attempted to terminate its 2005 collaboration agreement with GTC for alleged cause. LEO made it clear that its decision to seek termination was not based on any safety or efficacy issues regarding ATryn?, and GTC does not believe that LEO had any basis for such termination. GTC believes it is taking necessary and appropriate steps to protect its legal rights through the arbitration process and the notice of termination. >
If LEO wanted to simply walk away they could have done so quickly. I look at what happened is that was objecting to how much money it would have to pay to GTCB so the process was dragging on for too long. GTCB finally decided it had enough and sued to force the issue so that they can move on with rATIII. I don't think anything that GTCB does or says could change your attitude. You keep behaving as a spurned suitor, viewing everything has done in the past or is doing now as a negative, and desperately hoping that GTCB fails. It is amazing to watch your transition from major GTCB advocate to major GTCB critic.
